Lifecore Biomedical’s Upcoming Investor Conferences and Industry Events
CHASKA, Minn., Feb. 26, 2025 – Lifecore Biomedical, Inc. (NASDAQ: LFCR), a leading contract development and manufacturing organization (CDMO), has announced its participation in several upcoming investor conferences and industry events. These events provide an excellent opportunity for Lifecore to showcase its capabilities, engage with industry professionals, and discuss its business strategy with investors.
Investor Conferences
First, Lifecore will present at the 19th Annual B. Riley Securities Consumer and Retail Conference on March 8, 2025. The presentation is scheduled for 11:30 a.m. Eastern Time and will be webcast live. Investors interested in attending the conference can register on the B. Riley Securities website.
Additionally, Lifecore will participate in the 39th Annual ROTH Conference on March 11-13, 2025. This conference brings together growth companies and institutional investors. Lifecore’s management team is scheduled for one-on-one meetings with investors. More information about the ROTH Conference can be found on the conference website.
Industry Events
Beyond investor conferences, Lifecore will also attend the Interphex Expo in New York City on April 17-19, 2025. This annual event is one of the largest expos for the pharmaceutical, biotech, and medical device industries. Lifecore will showcase its capabilities in contract development, manufacturing, and testing services for the biopharmaceutical industry.
Another industry event that Lifecore will attend is the Biotech Showcase™ in San Francisco on January 9-11, 2026. This event is an elite forum for presenting to and meeting with investors, industry analysts, and key executives. Lifecore’s management team will provide updates on the company’s progress and growth strategy.
Impact on Individuals
For individuals working in the biopharmaceutical industry, Lifecore’s participation in these conferences and events could lead to new business opportunities. These events bring together key industry players, creating a platform for networking, collaboration, and learning about the latest trends and technologies. Moreover, attending these events can help professionals stay informed about the latest developments in the industry and expand their professional network.
Impact on the World
On a larger scale, Lifecore’s participation in these events demonstrates the company’s commitment to innovation and growth in the biopharmaceutical industry. By showcasing its capabilities and engaging with industry professionals, Lifecore can contribute to the advancement of new treatments and therapies. Additionally, these events foster collaboration and knowledge sharing between industry players, ultimately driving progress and improving patient outcomes.
Conclusion
In summary, Lifecore Biomedical’s participation in multiple upcoming investor conferences and industry events signifies the company’s dedication to showcasing its capabilities and engaging with industry professionals. These events provide opportunities for networking, collaboration, and learning about the latest trends and technologies in the biopharmaceutical industry. For individuals working in the industry, attending these events can lead to new business opportunities and professional growth. On a larger scale, Lifecore’s involvement in these events contributes to the advancement of new treatments and therapies, driving progress and improving patient outcomes.
- Lifecore Biomedical to present at B. Riley Securities Consumer and Retail Conference on March 8, 2025
- Management team to attend 39th Annual ROTH Conference on March 11-13, 2025
- Lifecore to exhibit at Interphex Expo in New York City on April 17-19, 2025
- Management team to present at Biotech Showcase™ in San Francisco on January 9-11, 2026
- Individuals in the biopharmaceutical industry can attend these events for networking, collaboration, and learning opportunities
- Lifecore’s involvement in these events contributes to the advancement of new treatments and therapies
